We are live on ! Find out more
DBTX

Decibel Therapeutics, Inc. Common Stock
DBTX

Delisted

DBTX was delisted on the 22nd of September, 2023.

Back to rankings

39 hedge funds and large institutions have $53.8M invested in Decibel Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

3% less funds holding

Funds holding: 40 → 39 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

34% less capital invested

Capital invested by funds: $81.7M → $53.8M (-$27.9M)

Holders
39
Holders Change
-1
Holders Change %
-2.5%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
9
Reduced
9
Closed
5
Calls
$343K
Puts
–
Net Calls
+$343K
Net Calls Change
-$139K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.07M
2
Barclays
Barclays
United Kingdom
+$921K
3
MA
MYDA Advisors
New York
+$76.6K
4
B
Bailard
California
+$75.5K
5
Morgan Stanley
Morgan Stanley
New York
+$36.7K

Top Sellers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
-$3.22M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$202K
3
Renaissance Technologies
Renaissance Technologies
New York
-$115K
4
Two Sigma Investments
Two Sigma Investments
New York
-$96K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$86.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
MA
26
MYDA Advisors
New York
$61K +$76.6K +20,000 New
B
27
Bailard
California
$60K +$75.5K +19,700 New
Bank of America
28
Bank of America
North Carolina
$56K +$19K +4,966 +36%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$51K -$86.5K -22,580 -57%
State Street
30
State Street
Massachusetts
$49K +$2.15K +560 +4%
Federated Hermes
31
Federated Hermes
Pennsylvania
$46K – – –
Northern Trust
32
Northern Trust
Illinois
$43K – – –
LCM
33
Laurion Capital Management
New York
$36K -$11.7K -3,063 -20%
FHA
34
Flagship Harbor Advisors
Massachusetts
$31K – – –
Acadian Asset Management
35
Acadian Asset Management
Massachusetts
$13K – – –
FIA
36
FNY Investment Advisers
New York
$9K +$12.3K +3,200 New
TRCT
37
Tower Research Capital (TRC)
New York
$2K -$2.74K -715 -51%
Citigroup
38
Citigroup
New York
$2K -$843 -220 -29%
Fidelity Investments
39
Fidelity Investments
Massachusetts
– -$202K -43,500 Closed
Two Sigma Advisers
40
Two Sigma Advisers
New York
– -$53K -11,300 Closed
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– -$5K -1,075 Closed
Optiver Holding
42
Optiver Holding
Netherlands
– -$7K -867 Closed
1
2

DBTX Hedge Fund Activity: Q1 2022 in Review

39 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q1 2022, worth a combined $53.8M — down 34% from $81.7M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of DBTX and 4 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 9 added.

The largest buyer was BlackRock, adding an estimated $3.07M. The largest seller was Casdin Capital, cutting an estimated $3.22M.

  • 39 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q1 2022, down from 40 in Q4 2021.
  • Funds reported $53.8M of Decibel Therapeutics, Inc. Common Stock stock for Q1 2022, down 34% quarter-over-quarter.
  • 4 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q1 2022 and 5 closed out, a net change of -1 holder.
  • The largest Decibel Therapeutics, Inc. Common Stock buyer in Q1 2022 was BlackRock, an estimated $3.07M added.
  • The largest Decibel Therapeutics, Inc. Common Stock seller in Q1 2022 was Casdin Capital, an estimated $3.22M sold.

Based on aggregated 13F filings for Q1 2022.